Electromedical Issues Shareholder Letter from the CEO on the Road Ahead for 2022

Electromedical Issues Shareholder Letter from the CEO on the Road Ahead for 2022

Post Views: 213 Electromedical Technologies, Inc. (OTC: EMED) (“Electromedical” or the “Company”), a pioneer in the development and manufacturing of bioelectronic devices, is pleased to issue the following Annual Letter to Shareholders from the Company’s Chief Executive Officer: Dear Valued Shareholder, Let me first express our tremendous gratitude to you for your loyalty, patience, and…